**Question:** Which of the following is least likely to cause weight gain?

A. Metformin
B. Acarbose
C. Pioglitazone
D. Insulin

**Core Concept:** Weight gain is a common side effect of certain medications, particularly those involved in the treatment of diabetes. Weight gain can occur due to increased appetite, fluid retention, or adipose tissue expansion.

**Why the Correct Answer is Right:** Metformin is a biguanide used in the treatment of type 2 diabetes. It is primarily an insulin sensitizer, improving insulin sensitivity in the muscles, liver, and adipose tissue. As a result, it does not cause significant weight gain due to its minimal effect on appetite and fluid balance.

**Why Each Wrong Option is Incorrect:**

**Option B (Acarbose):** Acarbose is another medication used for type 2 diabetes treatment. It is an alpha-glucosidase inhibitor, which blocks carbohydrate digestion and absorption, leading to increased postprandial blood glucose levels and potential weight gain due to carbohydrate overload.

**Option C (Pioglitazone):** Pioglitazone is a thiazolidinedione used for type 2 diabetes treatment. It is a PPAR-gamma agonist, increasing insulin sensitivity and decreasing gluconeogenesis, leading to weight gain through adipose tissue expansion.

**Option D (Insulin):** Insulin is a hormone produced by the pancreas and essential for glucose homeostasis. High insulin levels can lead to increased appetite, causing weight gain.

**Clinical Pearl:** When selecting a medication for diabetes treatment, considering the potential for weight gain and other side effects is essential to optimize therapeutic outcomes and patient satisfaction. In the context of this question, acarbose is the least suitable option due to its association with weight gain.